Related Experiment Video
Updated: Apr 15, 2026

Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells
Published on: March 3, 2016
NF1 loss induces senescence during human melanocyte differentiation in an iPSC-based model
Lionel Larribere1,2, Huizi Wu1,2, Daniel Novak1,2
1Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Abstract:
Neurofibromatosis type 1 (NF1) is a frequent genetic disease leading to the development of Schwann cell-derived neurofibromas or melanocytic lesions called café-au-lait macules (CALMs). The molecular mechanisms involved in CALMs formation remain largely unknown. In this report, we show for the first time pathophysiological mechanisms of abnormal melanocyte differentiation in a human NF1(+/-) -induced pluripotent stem cell (iPSC)-based model. We demonstrate that NF1 patient-derived fibroblasts can be successfully reprogrammed in NF1(+/-) iPSCs with active RAS signaling and that NF1 loss induces senescence during melanocyte differentiation as well as in patient's-derived CALMs, revealing a new role for NF1 in the melanocyte lineage.
Insights
Neurofibromatosis type 1 (NF1) causes skin lesions. Researchers used patient stem cells to reveal that NF1 loss triggers senescence, impacting melanocyte differentiation and café-au-lait macule formation.
Area of Science:
- Genetics
- Developmental Biology
- Cell Biology
Background:
- Neurofibromatosis type 1 (NF1) is a common genetic disorder.
- NF1 is characterized by neurofibromas and café-au-lait macules (CALMs).
- The molecular basis of CALM development in NF1 is poorly understood.
Purpose of the Study:
- To investigate the molecular mechanisms underlying abnormal melanocyte differentiation in NF1.
- To establish and utilize a human induced pluripotent stem cell (iPSC) model for NF1 research.
Main Methods:
- Reprogramming of NF1 patient-derived fibroblasts into NF1(+/-) iPSCs.
- Analysis of melanocyte differentiation from NF1(+/-) iPSCs.
- Assessment of senescence in melanocytes and patient-derived CALMs.
Main Results:
- NF1(+/-) iPSCs exhibit active RAS signaling.
- NF1 loss leads to senescence during melanocyte differentiation.
- Senescence is also observed in CALMs from NF1 patients.
Conclusions:
- This study presents the first pathophysiological model of abnormal melanocyte differentiation in NF1 using human iPSCs.
- NF1 loss plays a critical role in inducing senescence in the melanocyte lineage.
- These findings uncover a novel function of NF1 in melanocyte development and CALM formation.
Related Concept Videos
iPS Cell Differentiation
EPS and iPS Cells in Disease Research

